Now Approved—The only type 2 diabetes medicine proven to lower the risks of:

  • end-stage kidney disease (ESKD)
  • worsening of kidney function
  • cardiovascular death
  • hospitalization for heart failure

in adults with type 2 diabetes and diabetic kidney disease (nephropathy) with a certain amount of protein in the urine

Large Invokana logo in the shape of a pair of kidneys

Invokana logo in the shape of an hourglass

Diabetic kidney disease is a silent health threat. Don’t wait to find out if you have it.

Our kidneys clean our blood, balance fluids, regulate blood pressure, and more—so it's extremely important we take care of them. But type 2 diabetes can lead to diabetic kidney disease, a condition that has no early symptoms and can lead to transplant, dialysis, hospitalization for heart failure, or even death. Nearly 1 in 3 adults with type 2 diabetes has diabetic kidney disease—but your doctor can help, so be sure to have a conversation about it.

Janssen wants to help you explore cost support options for INVOKANA®.

We want to help! Cost support and more is available through the Janssen CarePath Savings program.